Isopentenyl pyrophosphate (IPP)

Isopentenyl pyrophosphate (IPP) is a critical five-carbon intermediate in the mevalonate pathway, essential for the biosynthesis of terpenes, cholesterol, and isoprenoids required for protein prenylation [PubChem CID 1195]. Beyond its metabolic role, IPP serves as a potent endogenous phosphoantigen that specifically activates Vγ9Vδ2 T cells, a subset of gamma-delta T cells involved in innate-like immune surveillance [PubMed PMID 10508212]. In many cancer cells, the mevalonate pathway is dysregulated, leading to elevated IPP levels that can trigger T cell-mediated cytotoxicity. Nitrogen-containing bisphosphonates, such as zoledronic acid, exploit this mechanism by inhibiting farnesyl pyrophosphate synthase (FPPS), resulting in the intracellular accumulation of IPP [PubMed PMID 17517914]. This accumulation promotes the conformational change of butyrophilin 3A1 (BTN3A1), which then presents IPP to gamma-delta T cells, making it a focal point for developing novel cancer immunotherapies [PubMed PMID 23601261]. The interaction between IPP and the B30.2 domain of BTN3A1 is a prerequisite for the activation of the Vγ9Vδ2 T cell receptor. This unique mechanism of action allows for the selective targeting of cells with high metabolic turnover, such as tumor cells or cells infected with certain pathogens. Therapeutic strategies often involve the use of aminobisphosphonates to sensitize tumors to gamma-delta T cell-mediated killing. Additionally, synthetic analogs of IPP are being explored as direct activators of the immune system in clinical trials.

Other names

Isopentenyl diphosphate3-Methylbut-3-en-1-yl diphosphate3-Methyl-3-butenyl pyrophosphateIsoprenyl pyrophosphate

Nitrogen-containing bisphosphonates inhibit the enzyme farnesyl pyrophosphate synthase (FPPS) in the mevalonate pathway, which leads to the upstream accumulation of isopentenyl pyrophosphate (IPP) within cells [PubMed PMID 17517914]. This accumulated IPP binds to the B30.2 intracellular domain of butyrophilin 3A1 (BTN3A1), inducing a conformational change that is sensed by the Vγ9Vδ2 T cell receptor, thereby triggering T cell activation and proliferation against target cells [PubMed PMID 23601261].